Date | Company | Valuation | Exit | Acquirer | Press Mentions |
---|---|---|---|---|---|
2019-09-03 | Semma Therapeutics | $950M | Acquired | www.benzinga.com, www.semma-tx.com, www.genengnews.com, www.biopharmadive.com, www.businesswire.com, and www.bizjournals.com | |
2018-10-31 | Orchard Therapeutics | $1.16332B | IPO | pro.edgar-online.com, www.pehub.com, Xconomy, www.bioportfolio.com, and www.b3cnewswire.com | |
2018-06-28 | Forty Seven | $474M | IPO | www.bizjournals.com, www.nasdaq.com, and www.biocentury.com | |
2014-04-29 | iPierian | $175M | Acquired | PR Newswire | |
2013-06-19 | Bluebird Bio | $371.78M | IPO | bostonherald.com, Xconomy, and www.boston.com |